DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2056866
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP2056866
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2019-08-10 | botulinum toxin type b | Elan Pharm | MYOBLOC |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |